eMedicine Specialties > Ophthalmology > Dermatologic Disorders

Ichthyosis: Differential Diagnoses & Workup

Author: Kenneth M Goins, MD, Professor of Clinical Ophthalmology, Director of Cornea and External Diseases and Refractive Surgery, Department of Ophthalmology, University of Iowa Hospitals and Clinics; Medical Director of Iowa Lions Eye Bank
Coauthor(s): Seth Adam Anderson, Des Moines University College of Osteopathic Medicine
Contributor Information and Disclosures

Updated: Dec 12, 2007

Differential Diagnoses

Acrodermatitis Enteropathica
Leukemias
Acute Retinal Necrosis
Ocular Manifestations of Syphilis
Dermatitis, Atopic
Psoriasis
Herpes Zoster
Retinitis Pigmentosa
HIV
Sarcoidosis
Kaposi Sarcoma
Thyroid Ophthalmopathy

Other Problems to Be Considered

Tuberculosis

Workup

Laboratory Studies

  • In some congenital ichthyosiform disorders, routine histopathology, electron microscopy, and frozen sections of skin biopsy specimens may be required to determine the specific classification of disease. Tests that may be required to diagnose the type of ichthyosis may include the following:
    • Ichthyosis vulgaris - Skin biopsy
    • X-linked recessive ichthyosis – STS activity or levels of cholesterol sulfate and genetic testing of amniotic fluid for partial or complete deletion of the STS gene mapped on band Xp22.3
    • Epidermolytic hyperkeratosis - Skin biopsy and keratin gene studies
    • Lamellar ichthyosis – Genetic analysis for mutations in the gene for transglutaminase 1, leading to greatly reduced skin transglutaminase activity by radiometric assay
    • CHILD syndrome - Radiographic and molecular genetic studies for mutations in an essential enzyme of cholesterol biosynthesis, NAD(P)H steroid dehydrogenase
    • KID syndrome - Skin biopsy and molecular genetic analysis for mutations in the GJB2 gene, coding for connexin 26, a component of gap junctions in epithelial cells
    • Neutral lipid storage disease - Blood smear for vacuoles and skin biopsy
    • Refsum disease - Plasma phytanic levels
    • Netherton syndrome - Hair shaft examination
    • Sjögren-Larsson syndrome - Fatty alcohol:NAD oxidoreductase assay
  • Acquired ichthyosis may be a marker of various autoimmune disorders or malignancy. Acquired ichthyosis may also be a marker of concomitant infection with HIV in intravenous drug users and occurs after profound helper T-cell depletion. Important laboratory tests to consider in addition to HIV testing are as follows:
    • CBC with differential and bone marrow aspirate (ie, leukemia, myelodysplastic syndromes)
    • Thyroid function tests (ie, hypothyroidism)
    • Serum angiotensin converting enzyme and lysozyme (ie, sarcoidosis)
    • Chest x-ray (ie, sarcoidosis, lymphoma, HIV, tuberculosis)
    • Serum antinuclear antibody (ANA), anti-double stranded DNA (dsDNA) antibody, anticentromere antibody (ACA), and anti-Scl-70 antibody (ie, systemic lupus erythematosus [SLE], systemic sclerosis)

Imaging Studies

  • In congenital ichthyosis syndromes, excessive intra-amniotic debris and polyhydramnios on ultrasound scanning in utero may be the first indication of disease.
    • Using ultrasound scanning in utero, fetal foot length may be an important and probably the first marker, seen in the second trimester, for the diagnosis of harlequin ichthyosis.
    • Other echographic findings may include a persistently open mouth, dense amniotic fluid, and fixed flexion of the extremities.

Other Tests

  • Studies have shown that a low maternal serum unconjugated estriol during pregnancy screening may be a good indication of placental STS deficiency and X-linked recessive ichthyosis.
  • Microdeletion of the STS gene can be confirmed by fluorescence in situ hybridization (FISH) analysis of cultured amniotic fluid in X-linked ichthyosis.
  • Prenatal diagnosis of lamellar ichthyosis can be made by direct mutational analysis of the keratinocyte transglutaminase gene.

Procedures

  • Fetal skin biopsy that examines keratinized hair canals and amniotic fluid at approximately 19 weeks estimated gestation age may provide an early diagnosis of certain forms of ichthyosis (ie, Harlequin type, which is extremely severe and usually fatal).

Histologic Findings

In ichthyosis vulgaris, the affected skin displays mild hyperkeratosis and a diminished granular layer in the epidermis, while the dermis has normal features.

Affected skin in X-linked ichthyosis shows an expanded stratum corneum without parakeratosis or acanthosis. In contrast to ichthyosis vulgaris, the granular cell layer may be normal. However, in some cases, it may be absent, which makes histologic differentiation from ichthyosis vulgaris very difficult.

Lamellar ichthyosis displays massive, compact orthohyperkeratosis with variable degrees of parakeratosis and a markedly thick stratum corneum. The granular layer is either normal or increased.

In epidermolytic hyperkeratosis, the skin biopsy specimen shows epidermal acanthosis and hyperkeratosis. Bullous formation may be manifested by intercellular and intracellular spaces as a result of suprabasal cytolysis within the granular layer.

The skin biopsy specimen from patients with CIE shows incomplete thickening of the cornified cell envelope and abnormal lipid droplets in the cells.

More on Ichthyosis

Overview: Ichthyosis
Differential Diagnoses & Workup: Ichthyosis
Treatment & Medication: Ichthyosis
Follow-up: Ichthyosis
Multimedia: Ichthyosis
References

References

  1. Akiyama M, Suzumori K, Shimizu H. Prenatal diagnosis of harlequin ichthyosis by the examination of keratinized hair canals and amniotic fluid cells at 19 weeks' estimated gestational age. Prenat Diagn. Feb 1999;19(2):167-71. [Medline].

  2. Al-Akloby OM. Association of atopic dermatitis with primary hereditary ichthyoses. Saudi Med J. Aug 2004;25(8):1097-9. [Medline].

  3. Baden HP, Imber M. Ichthyosis with an unusual constellation of ectodermal dysplasias. Clin Genet. Jun 1989;35(6):455-61. [Medline].

  4. Bale SJ, DiGiovanna JJ. Genetic approaches to understanding the keratinopathies. Adv Dermatol. 1997;12:99-113; discussion 114. [Medline].

  5. Banse-Kupin L, Pelachyk JM. Ichthyosiform sarcoidosis. Report of two cases and a review of the literature. J Am Acad Dermatol. Oct 1987;17(4):616-20. [Medline].

  6. Bitoun E, Chavanas S, Irvine AD, Lonie L, Bodemer C, Paradisi M. Netherton syndrome: disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol. Feb 2002;118(2):352-61. [Medline].

  7. Caceres-Rios H, Tamayo-Sanchez L, Duran-Mckinster C, de la Luz Orozco M, Ruiz-Maldonado R. Keratitis, ichthyosis, and deafness (KID syndrome): review of the literature and proposal of a new terminology. Pediatr Dermatol. Mar-Apr 1996;13(2):105-13. [Medline].

  8. Casaroli Marano RP, Ortiz Stradtmann MA, Uxo M, Iglesias E. Ocular findings associated with congenital X-linked ichthyosis. Ann Ophthalmol. May 1991;23(5):167-72. [Medline].

  9. Chiaretti A, Schembri Wismayer D, Tortorolo L, Piastra M, Polidori G. Salicylate intoxication using a skin ointment. Acta Paediatr. Mar 1997;86(3):330-1. [Medline].

  10. Costagliola C, Fabbrocini G, Illiano GM, Scibelli G, Delfino M. Ocular findings in X-linked ichthyosis: a survey on 38 cases. Ophthalmologica. 1991;202(3):152-5. [Medline].

  11. Cuevas-Covarrubias SA, Diaz-Zagoya JC, Rivera-Vega MR, Beirana A, Carrasco E, Orozco E, et al. Higher prevalence of X-linked ichthyosis vs. ichthyosis vulgaris in Mexico. Int J Dermatol. Jul 1999;38(7):555-6. [Medline].

  12. Culican SM, Custer PL. Repair of cicatricial ectropion in an infant with harlequin ichthyosis using engineered human skin. Am J Ophthalmol. Sep 2002;134(3):442-3. [Medline].

  13. Derse M, Wannke E, Payer H, Rohrbach JM, Zierhut M. [Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)]. Klin Monatsbl Augenheilkd. May 2002;219(5):383-6. [Medline].

  14. Dilek I, Demirer T, Ustün C, Arat M, Koç H, Beksac M, et al. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. Bone Marrow Transplant. Jun 1998;21(11):1159-61. [Medline].

  15. Gicquel JJ, Lami MC, Catier A, Balayre S, Dighiero P. [Limbal stem cell deficiency associated with KID syndrome, about a case]. J Fr Ophtalmol. Dec 2002;25(10):1061-4. [Medline].

  16. Gloerich J, Ijlst L, Wanders RJ, Ferdinandusse S. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome. Mol Genet Metab. Sep-Oct 2006;89(1-2):111-5. [Medline].

  17. Happle R, Hoffmann R. Absence of male-pattern baldness in men with X-linked recessive ichthyosis? A hypothesis to be challenged. Dermatology. 1999;198(3):231-2. [Medline].

  18. Hazan C, Orlow SJ, Schaffer JV. X-linked recessive ichthyosis. Dermatol Online J. 2005;11(4):12. [Medline].

  19. Hoffjan S, Stemmler S. On the role of the epidermal differentiation complex in ichthyosis vulgaris, atopic dermatitis and psoriasis. Br J Dermatol. Sep 2007;157(3):441-9. [Medline].

  20. Hosomi N, Oiso N, Fukai K, Hanada K, Fujita H, Ishii M. Deletion of distal promoter of VCXA in a patient with X-linked ichthyosis associated with borderline mental retardation. J Dermatol Sci. Jan 2007;45(1):31-6. [Medline].

  21. Hummel M, Cunningham D, Mullett CJ, Kelley RI, Herman GE. Left-sided CHILD syndrome caused by a nonsense mutation in the NSDHL gene. Am J Med Genet A. Oct 15 2003;122(3):246-51. [Medline].

  22. Ingordo V, D'Andria G, Gentile C, Decuzzi M, Mascia E, Naldi L. Frequency of X-linked ichthyosis in coastal southern Italy: a study on a representative sample of a young male population. Dermatology. 2003;207(2):148-50. [Medline].

  23. Kaplan MH, Sadick NS, McNutt NS, Talmor M, Coronesi M, Hall WW. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J Am Acad Dermatol. Nov 1993;29(5 Pt 1):701-8. [Medline].

  24. Kawashima J, Akiyama M, Takizawa Y, Takahashi S, Matsuo I, Shimizu H. Structural, enzymatic and molecular studies in a series of nonbullous congenital ichthyosiform erythroderma patients. Clin Exp Dermatol. Jul 2005;30(4):429-31. [Medline].

  25. König A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet. Feb 14 2000;90(4):339-46. [Medline].

  26. Küster W, Bohnsack K, Rippke F, Upmeyer HJ, Groll S, Traupe H, et al. Efficacy of urea therapy in children with ichthyosis. A multicenter randomized, placebo-controlled, double-blind, semilateral study. Dermatology. 1998;196(2):217-22. [Medline].

  27. Lacz NL, Schwartz RA, Kihiczak G. Epidermolytic hyperkeratosis: a keratin 1 or 10 mutational event. Int J Dermatol. Jan 2005;44(1):1-6. [Medline].

  28. Lee HW, Ahn SJ, Choi JC, Chang SE, Choi JH, Moon KC, et al. Acquired ichthyosis associated with an overlap syndrome of systemic sclerosis and systemic lupus erythematosus. J Dermatol. Jan 2006;33(1):52-4. [Medline].

  29. Leung PC, Ma GF. Ectropion of all four eyelids associated with severe ichthyosis congenita: a case report. Br J Plast Surg. Jul 1981;34(3):302-4. [Medline].

  30. Lucker GP, Heremans AM, Boegheim PJ, van de Kerkhof PC, Steijlen PM. Oral treatment of ichthyosis by the cytochrome P-450 inhibitor liarozole. Br J Dermatol. Jan 1997;136(1):71-5. [Medline].

  31. Marulli GC, Campione E, Chimenti MS, Terrinoni A, Melino G, Bianchi L. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol. Jul 2003;28(4):391-3. [Medline].

  32. Mayuzumi N, Ikeda S, Kawada H, Ogawa H. Effects of drugs and anticytokine antibodies on expression of ATP2A2 and ATP2C1 in cultured normal human keratinocytes. Br J Dermatol. May 2005;152(5):920-4. [Medline].

  33. Messmer EM, Kenyon KR, Rittinger O, Janecke AR, Kampik A. Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome. Ophthalmology. Feb 2005;112(2):e1-6. [Medline].

  34. Montague I, Fox R, Mann R. Intra-amniotic debris identified at ultrasound scanning: a feature of congenital ichthyosis. Ultrasound Obstet Gynecol. May 1997;9(5):350-1. [Medline].

  35. Moran JL, Qiu H, Turbe-Doan A, Yun Y, Boeglin WE, Brash AR, et al. A mouse mutation in the 12R-lipoxygenase, Alox12b, disrupts formation of the epidermal permeability barrier. J Invest Dermatol. Aug 2007;127(8):1893-7. [Medline].

  36. Moskowitz DG, Fowler AJ, Heyman MB, Cohen SP, Crumrine D, Elias PM, et al. Pathophysiologic basis for growth failure in children with ichthyosis: an evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr. Jul 2004;145(1):82-92. [Medline].

  37. Oji V, Beljan G, Beier K, Traupe H, Luger TA. Topical pimecrolimus: a novel therapeutic option for Netherton syndrome. Br J Dermatol. Nov 2005;153(5):1067-8. [Medline].

  38. Orth DH, Fretzin DF, Abramson V. Collodion baby with transient bilateral upper lid ectropion. Review of ocular manifestations in ichthyosis. Arch Ophthalmol. Mar 1974;91(3):206-7. [Medline].

  39. Pagliaro JA, White SI. Specific skin lesions occurring in a patient with Hodgkin's lymphoma. Australas J Dermatol. Feb 1999;40(1):41-3. [Medline].

  40. Patel N, Spencer LA, English JC 3rd, Zirwas MJ. Acquired ichthyosis. J Am Acad Dermatol. Oct 2006;55(4):647-56. [Medline].

  41. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynanen M, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. May 2002;70(5):1341-8. [Medline].

  42. Sarici SU, Sahin M, Yurdakök M. Topical N-acetylcysteine treatment in neonatal ichthyosis. Turk J Pediatr. Jul-Sep 2003;45(3):245-7. [Medline].

  43. Schnur RE, Greenbaum BH, Heymann WR, Christensen K, Buck AS, Reid CS, et al. Acute lymphoblastic leukemia in a child with the CHIME neuroectodermal dysplasia syndrome. Am J Med Genet. Oct 3 1997;72(1):24-9. [Medline].

  44. Schorderet DF, Huber M, Laurini RN, Von Moos G, Gianadda B, Deleze G, et al. Prenatal diagnosis of lamellar ichthyosis by direct mutational analysis of the keratinocyte transglutaminase gene. Prenat Diagn. May 1997;17(5):483-6. [Medline].

  45. Shwayder T. Disorders of keratinization: diagnosis and management. Am J Clin Dermatol. 2004;5(1):17-29. [Medline].

  46. Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. Jun 2006;45(6):693-7. [Medline].

  47. Suresh S, Vijayalakshmi R, Indrani S, Lata M. Short foot length: a diagnostic pointer for harlequin ichthyosis. J Ultrasound Med. Dec 2004;23(12):1653-7. [Medline].

  48. Takechi K, Sekiguchi K, Goto S. [A case of keratitis, ichthyosis, and deafness syndrome with Hutchinson's triad-like symptoms]. Nippon Ganka Gakkai Zasshi. Apr 1999;103(4):322-6. [Medline].

  49. Thiers BH. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis. J Am Acad Dermatol. Sep 1997;37(3 Pt 2):S69-71. [Medline].

  50. Traboulsi E, Waked N, Megarbane H. Ocular findings in ichthyosis follicularis-alopecia-photophobia (IFAP) syndrome. Ophthalmic Genet. Jun 2004;25(2):153-6. [Medline].

  51. Tsochatzis E, Vassilopoulos D, Deutsch M, Asvesti C, Sevastos N, Archimandritis AJ. Myelodysplastic syndrome presenting as acquired ichthyosis. Eur J Intern Med. Aug 2006;17(5):368-9. [Medline].

  52. Zhong W, Cui B, Zhang Y, Jiang H, Wei S, Bu L, et al. Linkage analysis suggests a locus of ichthyosis vulgaris on 1q22. J Hum Genet. 2003;48(7):390-2. [Medline].

Further Reading

Keywords

ichthyosis vulgaris, lamellar ichthyosis, epidermolytic hyperkeratosis, X-linked ichthyosis, acquired ichthyosis

Contributor Information and Disclosures

Author

Kenneth M Goins, MD, Professor of Clinical Ophthalmology, Director of Cornea and External Diseases and Refractive Surgery, Department of Ophthalmology, University of Iowa Hospitals and Clinics; Medical Director of Iowa Lions Eye Bank
Kenneth M Goins, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Eye Bank Association of America, International Society of Refractive Surgery, and Iowa Medical Society
Disclosure: Nothing to disclose.

Coauthor(s)

Seth Adam Anderson, Des Moines University College of Osteopathic Medicine
Disclosure: Nothing to disclose.

Medical Editor

Andrew A Dahl, MD, Director of Ophthalmology Teaching, Mid-Hudson Family Practice Institute, The Institute for Family Health; Assistant Professor of Surgery (Ophthalmology), New York College of Medicine
Andrew A Dahl, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Mark T Duffy, MD, PhD, Consulting Staff, Division of Oculoplastic, Orbito-facial, Lacrimal and Reconstructive Surgery, Green Bay Eye Clinic, BayCare Clinic; Medical Director, Advanced Cosmetic Solutions, A BayCare Clinic
Mark T Duffy, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Ophthalmic Plastic and Reconstructive Surgery, Sigma Xi, and Society for Neuroscience
Disclosure: Allergan - Botox Cosmetic Consulting fee Consulting; Quest medical - lacrimal balloons Honoraria Speaking and teaching; Ortho-Neutrogenia Consulting fee Consulting

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.